These final results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the thought of targeting ACKR3 as a unique method to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked disorders. Hi. I just wanted https://aabyee268ole5.popup-blog.com/profile